Similar articles

• Terazosin, finasteride, or both in benign prostatic hyperplasia.

  Thien T, Lenders JW. Thien T, et al. N Engl J Med. 1997 Jan 23;336(4):294. doi: 10.1056/NEJM199701233360413. N Engl J Med. 1997. PMID: 9005318 No abstract available.
• [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].

  Sivkov AV, Apolikhin OI, Medvedev AA. Sivkov AV, et al. Urol Nefrol (Mosk). 1997 Sep-Oct;(5):50-3. Urol Nefrol (Mosk). 1997. PMID: 9412019 Review. Russian. No abstract available.
• [Terazosin].

  Schäfers RF, Michel MC. Schäfers RF, et al. Dtsch Med Wochenschr. 1998 Apr 9;123(15):459-60. doi: 10.1055/s-0029-1233226. Dtsch Med Wochenschr. 1998. PMID: 9581161 Review. German. No abstract available.
• Terazosin now indicated for benign prostatic hyperplasia.

  [No authors listed] [No authors listed] Am J Hosp Pharm. 1994 Jan 1;51(1):25. Am J Hosp Pharm. 1994. PMID: 7510930 No abstract available.
• Terazosin, finasteride, or both in benign prostatic hyperplasia.

  Kuchel GA, DuBeau CE, Resnick NM. Kuchel GA, et al. N Engl J Med. 1997 Jan 23;336(4):293-4; author reply 294. doi: 10.1056/NEJM199701233360412. N Engl J Med. 1997. PMID: 9005317 No abstract available.